Company Filing History:
Years Active: 2003-2005
Title: Innovations by Mark Legaz
Introduction
Mark Legaz is an accomplished inventor based in Longview, Washington. He has made significant contributions to the field of enzymatic assays, holding a total of three patents. His work focuses on improving the assessment of important biochemical markers in various solutions, including blood and urine.
Latest Patents
One of Mark Legaz's latest patents is an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution. This innovative assay involves contacting a solution containing these compounds to form a reaction mixture with CBS, L-serine, and CBL. The process catalyzes the cyclical conversion of homocysteine to cystathionine and vice versa, producing pyruvate and ammonia. The assay allows for the determination of homocysteine and/or ammonia levels in the reaction mixture, which can then be used to assess the original concentrations in the solution. Notably, this assay can be conducted in 15 minutes or less, utilizing minimal enzyme resources.
Career Highlights
Mark Legaz has built a career centered around his expertise in enzymatic assays. His innovative approaches have led to advancements in the field, particularly in the rapid assessment of biochemical markers. He is currently associated with Catch, Inc., where he continues to develop and refine his inventions.
Collaborations
Mark has collaborated with notable colleagues, including Glenn H Kawasaki and Heather Kay Webb. These partnerships have contributed to the successful development and implementation of his innovative assays.
Conclusion
Mark Legaz is a prominent inventor whose work in enzymatic cycling assays has the potential to significantly impact the field of biochemical analysis. His contributions continue to advance the understanding and assessment of critical health markers.